4Krueger G,Koo J,Lebwohl M,et al.The impact of psoriasis on quality of life:results of a 1998 National Psoriasis Foundation patientmembership survey[J].Arch Dermatol,2001,37(3):280-284.
5Koo J.Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment[J].Dermatol Clin,1996,14(3):485-496.
6Koo J.Population-based epidemiologic study d psoriasis with emphasis on quality of life assessment[J].Dermatol Clin,1996,14(3):485-96.
7Langley BG,Krueger GG,Griffiths CE.Psoriasis:epidemiology,clinical features,and quality of life[J].Ann Rheum Dis,2005,64(2):18-23.
8Brasthen LR,Botten G,Bjerkedal T.Prevalence of psoriasis in Norway[J].Acta Derm Venereol (Stockh),1989,Suppl 142:5-8.
9Ferrándiz C,Bordas X,Garcia-Patos V,et al.Prevalence of psoriasis in Spain (Epiderma Project:phase Ⅰ)[J].J Eur Acad Dermatol Venereol,2001,15 (1):20-23.
10Gelfand JM,Weinstein R,Porter SB,et al.Prevalence and treatment of psoriasis in the United Kingdom:a population-based study[J].Arch Dermatol,2005,141(12):537-541.
